New techniques and devices made headway in tough treatment scenarios, and guidelines stressed the need for collaborative care ...

In partnership with Dr Bart Dolmatch at Palo Alto Medical Foundation, the company developed the device in 2010.

The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.

With approval, the company can begin commercializing the device in the U.S. in 2025.

Merit stated that Wrapsody is designed to extend long-term vessel patency in dialysis patients. The device’s covering features a nitinol stent frame enveloped by an expandable polytetrafluoroethylene ...